Kevin P Callahan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kevin P Callahan

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Frontiers in Pharmacology|February 15, 2013

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML PatientTorsten H Nielsen, Nathalie Johnson, Nicolas Garnier, et al.

The Journal of Biological Chemistry|October 4, 2013

Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cellsShanshan Pei, Mohammad Minhajuddin, Kevin P Callahan, et al.

Cancer Cell|June 18, 2013

In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signalingPeter G Miller, Fatima Al-Shahrour, Kimberly A Hartwell, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Frontiers in Pharmacology|February 15, 2013

Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML PatientTorsten H Nielsen, Nathalie Johnson, Nicolas Garnier, et al.

The Journal of Biological Chemistry|October 4, 2013

Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cellsShanshan Pei, Mohammad Minhajuddin, Kevin P Callahan, et al.

Cancer Cell|June 18, 2013

In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signalingPeter G Miller, Fatima Al-Shahrour, Kimberly A Hartwell, et al.

Pageof 2